Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.75 USD | 0.00% | -0.13% | +2.04% |
2023 | NGM Biopharmaceuticals Says Phase 2b Trial of Potential Cirrhosis Treatment Meets Primary Endpoint | MT |
2023 | Alpine 4 Holdings, Inc.(NasdaqCM:ALPP) dropped from S&P Global BMI Index | CI |
Valuation
Fiscal Period: December | 2018 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Capitalization 1 | 1.593 | 344.2 | 105.5 | 20.26 | 20.26 |
Enterprise Value (EV) 1 | 1.593 | 344.2 | 105.5 | 20.26 | 20.26 |
P/E ratio | -0.18 x | -16 x | -7.55 x | - | - |
Yield | - | - | - | - | - |
Capitalization / Revenue | 0.11 x | - | - | 0.18 x | 0.31 x |
EV / Revenue | 0.11 x | - | - | 0.18 x | 0.31 x |
EV / EBITDA | - | - | - | - | - |
EV / FCF | - | - | - | - | - |
FCF Yield | - | - | - | - | - |
Price to Book | - | - | - | - | - |
Nbr of stocks (in thousands) | 3,983 | 22,409 | 24,939 | 27,014 | 27,014 |
Reference price 2 | 0.4000 | 15.36 | 4.229 | 0.7500 | 0.7500 |
Announcement Date | 4/22/19 | 4/14/22 | 5/8/23 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales 1 | 14.26 | - | - | 112.2 | 64.46 |
EBITDA | - | - | - | - | - |
EBIT 1 | - | - | - | -15.14 | - |
Operating Margin | - | - | - | -13.48% | - |
Earnings before Tax (EBT) | - | - | - | - | - |
Net income | - | -19.41 | -12.88 | - | - |
Net margin | - | - | - | - | - |
EPS | -2.240 | -0.9600 | -0.5600 | - | - |
Free Cash Flow | - | - | - | - | - |
FCF margin | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 4/22/19 | 4/14/22 | 5/8/23 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2022 Q2 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | 28.02 | 29.64 | 30.22 | 16 | 14.4 | 15.84 |
EBITDA | - | - | - | - | - | - | - | - |
EBIT 1 | - | - | -3.719 | -3.557 | -2.72 | - | - | - |
Operating Margin | - | - | -13.27% | -12% | -9% | - | - | - |
Earnings before Tax (EBT) | - | - | - | - | - | - | - | - |
Net income | 2.026 | -5.769 | - | - | - | - | - | - |
Net margin | - | - | - | - | - | - | - | - |
EPS | 0.0800 | -0.2300 | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 8/12/22 | 6/21/23 | 8/11/23 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net Debt | - | - | - | - | - |
Net Cash position | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - |
Assets | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - |
Capex | - | - | - | - | - |
Capex / Sales | - | - | - | - | - |
Announcement Date | 4/22/19 | 4/14/22 | 5/8/23 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.04% | 20.26M | |
+12.06% | 107B | |
-0.62% | 29.43B | |
+12.05% | 22.21B | |
-16.05% | 17.75B | |
-6.34% | 17.25B | |
+8.74% | 15.28B | |
-4.89% | 12.2B | |
-2.85% | 10.42B | |
-8.86% | 9.04B |
- Stock Market
- Equities
- ALPP Stock
- Financials Alpine 4 Holdings, Inc.